Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.769 EUR | +2.26% | -2.04% | +78.84% |
Mar. 11 | Sensorion: study results in hearing loss | CF |
Mar. 11 | Sensorion Meets Primary Endpoint for Sens-401 Phase 2A Clinical Study for Residual Hearing Preservation | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock
- Equities
- Stock Sensorion - Euronext Paris
- Revisions Sensorion